Correlation Between Effector Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Immix Biopharma, you can compare the effects of market volatilities on Effector Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Immix Biopharma.
Diversification Opportunities for Effector Therapeutics and Immix Biopharma
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Effector and Immix is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Immix Biopharma
If you would invest 168.00 in Immix Biopharma on August 27, 2024 and sell it today you would earn a total of 11.00 from holding Immix Biopharma or generate 6.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Effector Therapeutics vs. Immix Biopharma
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Immix Biopharma |
Effector Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Immix Biopharma
The main advantage of trading using opposite Effector Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |